• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Titans with Belinda Tan of People Science

Microdose by Microdose
July 20, 2021
in Psychedelic Titans
Reading Time: 2 mins read
A A
Psychedelic Titans with Belinda Tan of People Science

This week’s Psychedelic Titan is Belinda Tan, Co-founder & Co-CEO of People Science. People Science is bringing better science to alternative medicine.

What’s this article series about? Psychedelic Titans is a get-to-know-you-style blog series interviewing some of the psychedelic industry’s most influential and impactful individuals.

When did you first become involved in the psychedelic industry and why?

I became more openly involved in 2020 when I started a company, People Science, to support clinical research for alternative medicines including psychedelics.

Do you, or have you taken, psychedelic substances?

I have taken psychedelic substances.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Do your parents/family members know what you’re doing?

Some of my family members know.

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Have you had an experience with mental health/chronic pain?

I struggled with depression when I was in medical school.

Belinda Tan of People Science

What’s your vision of the industry in 20 years?

This industry will transform how people and institutions view mental health and wellness, that its central role in optimizing health has been lost in the pathogenesis framework of western medicine. Increasing scientific evidence showing benefit to humanity will contribute to major shifts in beliefs that previously seemed unchangeable.

Purchase Official Lasix

What are your biggest worries for the industry?

I worry about the loss of fundamental human inner values like compassion and love in the race to profitability. I also worry about people repeatedly learning hard lessons about safety.

Who are your heroes?

I assume you mean in the psychedelic ecosystem? If so, my heroes are all of those who have had the strength to stand down to give the floor to somebody else (that is a quote by Kilindi Iyi about diversity). So many people want others to hear them, and even more, have something to say and cannot.

If you could create a psychedelic to do anything you wanted, what would it do?

It would pass the cultural belief sniff test and be perceived as “healthy” (it would be derived from a common plant that is not associated with being a “drug”) and would work in a way that the first effect would be to remove fear and anxiety and then follow with openness and compassion.

 

We’d like to thank Belinda for being a part of the Psychedelic Titans series. Stay tuned for weekly profiles on leaders in the psychedelic industry.

Would you like to participate in this series? Fill out this form and we’ll follow up with a review of your application.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: People Science
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Psychedelic Groundbreakers: Mycrodose Therapeutics

Psychedelic Groundbreakers: Mycrodose Therapeutics

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.